News
After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective weight-loss drugs, some U.S.
LONDON, GREATER LONDON, UNITED KINGDOM, May 23, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...
India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...
VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...
Employers have the opportunity to lead by example: to stop treating obesity as invisible and start addressing it as the ...
For a limited time, Wegovy will be available to new patients at $199 for the first month, Novo Nordisk said Thursday.
Under a mutual agreement with the board of directors, longtime Novo Nordisk CEO Lars Fruergaard Jørgensen—who recently shepherded the company through its GLP-1 growth boom—is heading for the exit.
The Trump administration released a 72-page report Thursday outlining its take on what's driving "a chronic disease crisis" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results